Showing posts with label patients. Show all posts
Showing posts with label patients. Show all posts

Saturday, October 5, 2013

Pharmacist-Guided Home Blood Pressure Monitoring May Help Patients

Study found combination led to better control of hypertensionStudy found combination led to better control of

By Serena Gordon

HealthDay Reporter

TUESDAY, July 2 (HealthDay News) -- Using home blood pressure monitoring and partnering with a pharmacist for lifestyle advice and medication changes led to better control of hypertension, a new study shows.

After six months of the intervention, nearly 72 percent of the study volunteers had their high blood pressure under control compared to 45 percent in the group that received usual care. Also, the effects of the intervention persisted even after the intervention ended. Six months later, about 72 percent of the intervention group had their high blood pressure under control compared to 57 percent in the usual care group.

"The reason that only about half of people with [high] blood pressure have it under control is that usual care isn't working. We combined two interventions that we thought would be very powerful together -- home monitoring and pharmacist managements -- and this is one system that we've shown works very well for blood pressure control," said senior investigator Dr. Karen Margolis, from the HealthPartners Institute for Education and Research in Minneapolis.

The findings appear in the July 3 issue of the Journal of the American Medical Association.

High blood pressure affects about 30 percent of U.S. adults, according to background information in the study. Treating and controlling high blood pressure can help prevent cardiovascular events, such as heart attacks. However, only about half of the adults in the United States with high blood pressure have it under control.

Home blood pressure monitoring has shown some success in helping people lower their blood pressure, so the researchers took that a step further and used telemonitoring devices that could send blood pressure readings to a pharmacist who could then adjust that person's blood pressure medication accordingly.

The study included 450 people receiving care at one of eight different clinics. All of the people recruited for the study had high blood pressure that wasn't well controlled.

The patients were randomized to receive either usual care (222 people) or the study intervention, which included blood pressure telemonitoring with pharmacist management.

In the study intervention group, each person received a home blood pressure monitor capable of sending readings to a secure website that a pharmacist monitored. At the start of the study, patients met with the pharmacist for an hour and were taught how to use the machines. They were also given lifestyle advice on lowering their blood pressure.

People in the study intervention group were asked to send at least six blood pressure readings from different times of the day to the pharmacist each week. During the first six months of the study, patients and pharmacists talked by phone every two weeks, until blood pressure was under control for at least six weeks, and then they talked monthly. During months seven to 12 of the study, the calls were reduced to every two months. During the calls, pharmacists reviewed lifestyle changes and emphasized adherence to medications.


View the original article here

Monday, September 30, 2013

Do Heart Patients Get Too Many Cholesterol Tests?

Unnecessary screenings contribute to rising U.S. health costs, study suggestsWithout treatment, virus can lead to liver cancer.

By Steven Reinberg

HealthDay Reporter

MONDAY, July 1 (HealthDay News) -- Many U.S. heart patients may be getting their cholesterol levels checked unnecessarily, a new study suggests.

Statistics on more than 35,000 patients with coronary heart disease treated in a Houston-based Veterans Affairs network suggest this is an area of over-testing that's contributing to the nation's soaring medical costs, the study authors said.

At this one network of seven hospitals, the cost of redundant cholesterol blood tests amounted to more than $200,000 in one year, the study found.

"These results represent health care resource overuse and possibly their waste," said lead researcher Dr. Salim Virani, a cardiologist at the Michael E. DeBakey Veterans Affairs Medical Center in Houston.

The study, published online July 1 in JAMA Internal Medicine, zeroed in on almost 28,000 patients taking statin drugs that were keeping their cholesterol levels in check -- less than 100 milligrams of cholesterol per deciliter of blood.

Over 11 months, repeat tests were ordered for one-third of those patients even though their medication had not been increased, the researchers found.

In all, nearly 13,000 additional tests were performed at about $16 each, bringing the total cost for this one group of hospitals to almost $204,000.

"Apart from the costs associated with these lipid panels, this also carries with it the cost for the patient's time to undergo a repeat blood test and cost for the health care provider's time to follow up on these results after redundant testing and to inform the patient about these results," said Virani.

Most of those who underwent repeat testing had a history of diabetes, high blood pressure and more frequent doctor visits, the research team found. The extra tests likely gave some of these patients a measure of comfort, the study authors noted.

The study drew mixed reactions from other experts.

Current national guidelines recommend that patients with coronary heart disease have their cholesterol checked every four to six months, said Dr. Gregg Fonarow, professor of cardiology at the University of California, Los Angeles and a spokesman for the American Heart Association.

"This new study shows a pattern of lipid testing that is entirely consistent with current guidelines," he said. "Whether less frequent testing and monitoring would result in similar outcomes at lower cost requires more study."

Using statin therapy to achieve and maintain appropriate LDL cholesterol levels remains one of the most cost-effective therapies for preventing recurrent cardiovascular events in men and women with coronary heart disease, he said.

Dr. Joseph Drozda Jr., author of an accompanying journal editorial, said that "seemingly inexpensive tests" really add up when done in large numbers.

"These cholesterol tests were being ordered with no benefit to the patient but cost the VA more than $200,000, and this was only in seven hospitals," said Drozda, from the Center for Innovative Care at Mercy Health in Chesterfield, Mo.

Drozda thinks this is just one example of the overuse of tests. "Most physicians will tell you this is not uncommon. A lot of tests are ordered without direct benefit to the patient and result in this kind of waste," he said.

"We need to be looking for all of these sources of waste and addressing them," he added.

About one of every six adult Americans has high blood cholesterol, putting them at risk of heart disease, according to the U.S. Centers for Disease Control and Prevention.


View the original article here

Wednesday, September 25, 2013

out patients vs in

Hello lovely people I have finally been contacted after 2 weeks of hell buy out patients to give me the option of in patients And I'm wondering what the major difrence a would be and if being in patente I could have my stuff like my paints with me? I have not asked yet my apponent is Friday

I'm really scared about it all


View the original article here

Thursday, September 19, 2013

Cancer Patients May Face Higher Bankruptcy Odds

News Picture: Cancer Patients May Face Higher Bankruptcy OddsBy Barbara Bronson Gray
HealthDay Reporter

WEDNESDAY, May 15 (HealthDay News) -- People diagnosed with cancer are almost three times more likely to declare bankruptcy than are those without the disease, a large new study suggests.

And younger people with cancer have up to five times higher bankruptcy rates compared to older patients with the disease, the researchers found.

Of almost 200,000 people with cancer in the study based in Washington state, about 2 percent filed for bankruptcy protection after being diagnosed. Of those who were not diagnosed with cancer, 1 percent filed.

Although the risk of bankruptcy for those with cancer is still relatively low, researchers said it is significant.

"Bankruptcy is such an extreme measure of financial distress, and we didn't include the other forms of financial difficulties people encounter," said Catherine Fedorenko, a study co-author and technical project coordinator at the Fred Hutchinson Cancer Research Center, in Seattle.

Whether people suffer substantial debt or have to go so far as to declare bankruptcy, their financial problems are likely to be stressful, said Karma Kreizenbeck, a study co-author and project director at the Hutchinson Institute for Cancer Outcomes Research.

"This paper shows how medical debt associated with a cancer diagnosis could be more likely to lead to a bankruptcy," Kreizenbeck said. "But it could also mean people have to take second jobs, end up with lower credit scores or have to make other decisions."

Celeste Smith, 63, was diagnosed five years ago with breast cancer. A Seattle realtor who was just starting to do well in a new job, she found she had to stop working when she was faced with months of radiation and chemotherapy. Despite the fact that she had health insurance, her mortgage and car payment bills began to mount. "It's a horrible circle trying to get over cancer and deal with all the financial stress," she said. Smith ended up filing for bankruptcy and moving from her foreclosed house to affordable living for seniors.

Researchers have noted before that the financial burden on people with cancer can be substantial. Data from the Medical Expenditure Panel Survey in 2004 showed that 6.5 percent of the $20.1 billion spent on cancer care by those not yet on Medicare each year comes directly from the patients themselves, according to study background information.

A small study presented last year at an American Society of Clinical Oncology meeting showed that four of every five cancer patients and their spouses or caregivers said they had concerns about meeting medical costs and suffered associated financial and mental stress.

The new research, published online May 15 and in the June print issue of Health Affairs, is based on data taken from a registry of people 21 and older who lived in Washington and were diagnosed with cancer from 1995 through 2009. They were compared to a randomly sampled population of people without cancer, matched by age, gender and ZIP code. Cancer cases were identified using a cancer registry based at the Fred Hutchinson Cancer Research Center, part of a U.S. National Cancer Institute epidemiology database.

Key findings of the new study include the following:

Cancer patients were 2.65 times more likely than people without cancer to go bankrupt.Those cancer patients who filed for bankruptcy were more likely to be younger, female and nonwhite than were cancer patients who didn't file. The youngest age groups had up to 10 times the bankruptcy rate compared to the older age groups. The youngest groups in the study were diagnosed at a time when their debt was typically high and their income was not, the study noted. Bankruptcy filings went up as time went by. While the proportion of cancer patients who filed for bankruptcy within one year of diagnosis was 0.52 percent, it went up to 1.7 percent after five years. Bankruptcy rates were highest for people with the diagnosis of thyroid and lung cancer, and lowest for melanoma, breast and prostate cancer. The authors suggested that the higher rate of bankruptcy associated with thyroid cancer was likely due to the fact that it affects younger women more often than do other cancers.

The study, based on data from 1995 to 2009, did not take into account the potential impact of the implementation of the Affordable Care Act (ACA) in 2010, an expert pointed out.

"The problem of bankruptcy was one thing the ACA was designed to address," said Peter Cunningham, a senior fellow and director of quantitative research at the Center for Studying Health System Change, in Washington, D.C.

Cunningham expressed concern that the researchers didn't note whether the cancer patients or the control participants had health insurance. "So we don't know how much of a difference having health insurance makes in terms of avoiding bankruptcy," he said. "It would have been nice to see what the impact of health insurance coverage is in being able to prevent bankruptcy and how many people lost their health insurance coverage because of their cancer diagnosis."

What should people do to avoid the stress of money troubles when faced with a serious disease? "The study points to the value of having health insurance," Cunningham said.

MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCES: Catherine Fedorenko, technical project coordinator, Fred Hutchinson Cancer Research Center, Seattle; Karma Kreizenbeck, project director, Hutchinson Institute for Cancer Outcomes Research, Seattle; Peter J. Cunningham, Ph.D., senior fellow and director of quantitative research, Center for Studying Health System Change, Washington, D.C.; Celeste Smith, Seattle; June 2013, Health Affairs



View the original article here

Monday, August 19, 2013

Hospitalization OK for Psych Patients Can Take Hours

News Picture: Hospitalization OK for Psych Patients Can Take Hours

WEDNESDAY, April 24 (HealthDay News) -- U.S. psychiatrists spend a total of 1 million hours on the phone each year getting insurance companies to approve hospitalization for patients with severe mental illnesses, a new study reports.

For the study, which was published April 23 in the journal Annals of Emergency Medicine, researchers looked at psychiatrists in the Boston area and found that they spent an average of 38 minutes per patient on the phone getting insurance authorization.

About one in 10 cases took more than an hour to get approval, and one case took up five hours of the psychiatrist's time, the investigators found.

Each year in the United States, there are about 1.6 million psychiatric admissions for patients with private insurance. An average of 38 minutes of phone time per patient to get insurance authorization works out to about 1 million hours of "wasted" time for psychiatrists nationwide, according to the news release from the Physicians for a National Health Program.

The three-month study did not include uninsured patients or those covered by Medicare, which does not require prior authorization.

Most of the patients that required hospitalization had been deemed suicidal or, in some cases, posed a danger to others. The time spent obtaining insurance authorization delayed care for the patient in need and prevented psychiatrists from seeing other patients, the study authors noted. Only one of the 53 requests for authorization was denied, they pointed out.

The average time that patients spent in an emergency department (ED) awaiting hospital admission was 8.5 hours. The shortest wait was three hours and the longest was 20 hours, according to the study findings.

Mental health disorders affect nearly one-quarter of American adults a year, but less than one-third of them receive psychiatric care, according to background information in the news release.

"Society pays for inadequate psychiatric care; more than half of all prison inmates and a third of all homeless people are mentally ill. Massachusetts is considered a model for health reform, yet we found that seriously ill patients routinely spent hours stranded in the ED due to insurance bureaucracy. The hours psychiatrists spend obtaining those authorizations could be far better spent treating our patients," study lead author Dr. Amy Funkenstein, a child psychiatry fellow at Brown University, said in the news release.

She led the study while she was a psychiatric resident at Cambridge Health Alliance (CHA) and Harvard Medical School.

Study senior author Dr. J. Wesley Boyd, attending psychiatrist at CHA, said that "private insurers are obstructing care by requiring authorizations before a qualified psychiatrist can hospitalize a dangerously ill patient. With doctors, nurses and emergency departments already overburdened, adding a time-consuming bureaucratic task that doesn't help patients is unconscionable," he said in the news release.

"Insurers hope that clinicians will be so hassled by authorization procedures that they won't seek admission for their patients, saving insurance companies money," Boyd, who is also an assistant clinical professor of psychiatry at Harvard Medical School, suggested in the news release. "Placing profits ahead of the health of patients when mental illness makes them vulnerable is immoral. A single-payer Medicare-for-all health care system would represent a great leap forward for patients and providers alike."

-- Robert Preidt MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCE: Physicians for a National Health Program, news release, April 23, 2013



View the original article here

Thursday, August 15, 2013

HIV Drugs May Help Protect Young Patients' Hearts: Study

Far from harming the cardiovascular health of infected children, drug cocktails may give benefitDrug abuse, prostitution tied to heightened risk,

By Robert Preidt

HealthDay Reporter

MONDAY, April 22 (HealthDay News) -- Long-term use of powerful drug cocktails known as highly active antiretroviral therapy (HAART) may help protect the hearts of children and teens infected with HIV, a new study reports.

HAART is a form of antiretroviral therapy that is widely used to treat people with HIV, the virus that causes AIDS. Prior to the introduction of antiretroviral therapies, youngsters infected with HIV were at increased risk for heart failure, noted a team led by Dr. Steven Lipshultz of the University of Miami Miller School of Medicine.

Since the advent of powerful HIV-suppressing medications, "the effects of HIV and [antiretroviral therapy] on the cardiovascular system of HIV-infected children are not completely understood," the researchers wrote in the April 22 online issue of JAMA Pediatrics. They pointed out that such children are exposed to these drugs for many years, often beginning while they are still in the womb, but the effects on their cardiovascular systems "are unknown."

The new study sought to clear that up. It included nearly 600 HIV-infected and uninfected patients from 14 pediatric HIV clinics across the United States.

According to the team, heart function was better among HIV-infected children receiving HAART than those who were infected with HIV and did not receive HAART, and children who were exposed to HIV but not infected.

"Our results indicate that the current use of combination [antiretroviral therapy], usually HAART, appears to be cardioprotective in HIV-infected children and adolescents," the study authors reported. "This finding is even more relevant in the developing world where the prevalence of HIV disease in children is much higher."

The researchers added that further study comparing different drug regimens might be beneficial "in optimizing HIV outcomes and protecting long-term cardiac health" of children with HIV.


View the original article here

Wednesday, August 7, 2013

Alzheimer's Patients May Face Looming Shortage of Neurologists

News Picture: Alzheimer's Patients May Face Looming Shortage of Neurologists

THURSDAY, April 18 (HealthDay News) -- For patients with Alzheimer's disease, Parkinson's disease, multiple sclerosis (MS) and other brain disorders, finding a specialist to treat their condition may be increasingly difficult, according to a new study.

Experts in the field of medicine that focuses on the brain and nervous system revealed that there is a shortage of neurologists in the United States as medical students and residents are choosing other more lucrative specialties. The study authors noted that patients with brain disorders who do find a neurologist would have to wait even longer to be treated.

"With the rapidly rising rates of brain diseases such as dementia and stroke at the same time as the number of U.S. medical residents choosing neurology over other specialties is clearly declining, the U.S. could face a crisis," explained study author Dr. Thomas Vidic, with Elkhart Clinic in Elkhart, Ind.

"Our study found that long wait times for patients to see a neurologist and difficulty finding neurologists to fill vacant positions are adding to the current national shortfall," Vidic, who is also a fellow with the American Academy of Neurology, said in an academy news release. "In addition, the demand for neurologists is expected to grow as people gain coverage through health care reform."

The study found that demand for neurologists would outpace supply over the next 12 years. Right now, 11 percent more neurologists are needed to meet patient demands. That number is expected to hit 19 percent by 2025. By that time, the researchers project the number of neurologists will increase to 18,060 as demand for this type of specialist surges to 21,440.

As a result, patients could be waiting even longer to get an appointment with a U.S. neurologist, the study findings indicate. Previous studies have shown new patients waited an average of 35 business days to see a neurologist last year.

The fact that the current Medicare payment system undervalues one-on-one evaluations by neurologists has led to the shortage of these specialists in the United States, the authors stated in the news release. They suggested that without fair reimbursement for neurological care, medical students and residents burdened by education debt will pursue more lucrative specialties.

This trend is particularly worrisome because brain diseases are becoming increasingly prevalent in the United States, the experts pointed out, with one in six Americans now currently affected by a neurological condition.

The study was published online April 17 in Neurology, just days before 150 neurologists were expected to head to Capitol Hill. The goal of the visit, scheduled for April 23, is to urge Congress to protect patients' access to neurologists through fair reimbursement for neurological care.

"We want Congress to act now to help alleviate this shortage at a time when baby boomers are aging and the number of people with Alzheimer's disease is expected to triple by 2050," American Academy of Neurology president, Dr. Timothy Pedley, said in the news release.

"Neurologists are the physicians best suited to care for the one in six people currently affected by neurological disease," Pedley explained. "It is therefore vital that they have access to neurologists who are specially trained in treating brain diseases."

-- Mary Elizabeth Dallas MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCE: American Academy of Neurology, news release, April 17, 2013



View the original article here

Wednesday, July 24, 2013

Cancer Patients May Be Unintended Victims of Budget Cuts

Clinics nationwide say they can't afford to give as much chemotherapy as before, report saysClinics nationwide say they can't afford to give

By Margaret Farley Steele

HealthDay Reporter

THURSDAY, April 4 (HealthDay News) -- Thousands of Medicare cancer patients are being denied treatment at clinics nationwide because of federal budget cuts related to the so-called sequester, according to a published report.

The mandated cuts took effect April 1, and cancer clinic administrators say they can no longer afford to provide expensive chemotherapy drugs to many Medicare patients, the Washington Post reported Wednesday. Medicare is the federal health insurance program for people 65 and older and certain others with disabilities.

After an emergency meeting Tuesday, one clinic administrator -- Jeff Vacirca, chief executive of North Shore Hematology Oncology Associates in New York -- told the Post that one-third of the group's 16,000 Medicare patients would be turned away.

"It's a choice between seeing these patients and staying in business," Vacirca told the newspaper. "The drugs we're going to lose money on we're not going to administer right now."

Hospitals, which also provide chemotherapy treatment, may offer an alternative, but it's not clear if they can accommodate the additional patients. Hospitals are also likely to charge more for treatment, and some of those extra costs will likely be borne by patients, said experts cited by the newspaper.

In terms of patients, the numbers are significant. Two-thirds of Medicare patients receive treatment in a community oncology clinic, rather than a hospital, according to a study by the Milliman actuarial firm, the Post reported.

This payment crunch is an unintended consequence of the sequester, some health care experts say. Congress limited Medicare to a 2 percent reduction -- less than that faced by other government programs -- but coverage of cancer drugs falls into a tricky area because they must be administered by a doctor. That puts them into the Medicare Part B category, which falls under the sequester cut, the Post reported.

"I don't think there was an intention to disrupt care or move it into a more expensive setting," said Cathy Schoen, senior vice president of the Commonwealth Fund, which works to promote a high-performing health-care system that achieves better access, improved quality and greater efficiency. "If that's the case, we're being penny-wise and a pound-foolish with these cuts," she told the Post.

Under current regulations, clinic oncologists receive federal reimbursement for the average price of cancer drugs, plus 6 percent for handling and administering them. Because doctors can't raise the drug price, the 2 percent cut has to come out of the 6 percent handling fee, they explained.

Some clinic administrators have urged lawmakers to shield cancer drugs from the sequester cuts, or put a 2 percent cap on reductions from their administrative reimbursement, the newspaper reported.

"We're hoping that something will change, as legislators see the impact of this," said Dr. Ralph Boccia, director of the Center for Cancer and Blood Disorders in Bethesda, Md.


View the original article here

Sunday, July 21, 2013

Study: Low Blood Pressure May Weaken Brains of Some Heart Patients

Pressure that's too low -- or too high -- might damage brain cells, new research suggestsPressure that's too low -- or too high -- might

By Steven Reinberg

HealthDay Reporter

MONDAY, June 10 (HealthDay News) -- People suffering from cardiovascular disease who have lower-than-normal blood pressure may face a higher risk of brain atrophy -- the death of brain cells or connections between brain cells, Dutch researchers report.

Such brain atrophy can lead to Alzheimer's disease or dementia in these patients. In contrast, similar patients with high blood pressure can slow brain atrophy by lowering their blood pressure, the researchers added.

Blood pressure is measured using two readings. The top number, called systolic pressure, gauges the pressure of blood moving through arteries. The bottom number, called diastolic pressure, measures the pressure in the arteries between heartbeats. Normal blood pressure for adults is less than 120/80, according to the U.S. National Heart, Lung, and Blood Institute.

For the study, 70 to 90 was considered normal diastolic blood pressure, while under 70 was considered low.

"Our data might suggest that patients with cardiovascular disease represent a subgroup within the general population in whom low diastolic blood pressure might be harmful," said researcher Dr. Majon Muller, an epidemiologist and geriatrician at VU University Medical Center in Amsterdam.

On the other hand, lowering blood pressure in people with high blood pressure might slow brain atrophy, she said.

"Our findings could imply that blood pressure lowering is beneficial in patients with higher blood pressure levels, but one should be cautious with further blood pressure lowering in patients who already have low diastolic blood pressure," Muller added.

The report was published in the June 10 online edition of JAMA Neurology.

A U.S. expert noted the complex effects of blood pressure levels on the brain.

"High blood pressure has been shown to increase the risk of vascular brain lesions and brain atrophy. Trials of blood pressure lowering in patients with hypertension have shown reduced risk of brain lesions," said Dr. Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles, and a spokesman for the American Heart Association.

However, in patients with hypertension, the relationship between the levels of systolic and diastolic blood pressure and brain atrophy has been less clear, he said.

This new study suggests that low diastolic blood pressure levels were associated with brain atrophy regardless of blood pressure levels after patients developed dementia, Fonarow said.

"These findings suggest that while treatment and control of high blood pressure is very important for brain and cardiovascular health, caution is needed in patients who have low diastolic blood pressure levels," he said.

To see what changes blood pressure would make in the progression of brain atrophy, Muller's group studied 663 patients who suffered from heart disease, cardiovascular disease, peripheral artery disease or abdominal aortic aneurysm. The average age of participants was 57 and most were men.

People whose diastolic blood pressure was below 70 had more brain atrophy over time, the study found. For people with higher-than-normal blood pressure, brain atrophy decreased when their blood pressure did. When blood pressure rose, however, atrophy increased.

Another expert, Dr. Sam Gandy, associate director of the Mount Sinai Alzheimer's Disease Research Center in New York City, said that the finding "is an important cautionary tale."

"This implies that one must adapt the approach to the individual patient. Correction of hypertension is helpful, but reducing blood pressure in patients with normal blood pressure is risky and complicated," Gandy said.

Although the study found an association between low diastolic blood pressure and the risk of developing brain atrophy for people with artery disease, it did not establish a cause-and-effect relationship.


View the original article here

New Strategy Helps Young Lymphoma Patients Avoid Radiation Treatment

Approach resulted in high remission rates without the risks tied to radiotherapy, researchers sayApproach resulted in high remission rates without

By Mary Elizabeth Dallas

HealthDay Reporter

WEDNESDAY, April 10 (HealthDay News) -- A new treatment approach may mean that young people with a form of lymphoma can go without radiation therapy, sparing them side effects or raised cancer risks down the road.

In a trial conducted by the U.S. National Cancer Institute, nearly all patients with a form of cancer known as primary mediastinal B-cell lymphoma who received chemotherapy, but did not undergo chest radiation, achieved a full remission.

Standard treatment for this cancer typically includes radiation to the chest, the study authors pointed out, but this has been linked to significant harmful effects in the future, particularly for women.

"These results are exciting and demonstrate that, using this approach, almost all patients appear to be cured and very few patients require radiation," study co-author Dr. Kieron Dunleavy, of the U.S. National Cancer Institute, said in an agency news release.

One expert not connected to the study agreed.

"This study is a significant achievement in improving the care of a group of lymphoma patients that urgently need it: young patients with an aggressive and -- if left untreated -- rapidly lethal disease," said Dr. Joshua Brody, assistant professor of medicine at the Icahn School of Medicine at Mount Sinai in New York City.

The study "yielded very exciting success rates with almost all patients going into complete remission even without the use of radiation therapy, which is frequently used for this disease," Brody added. All of the patients in the study maintained remission "for a long time," he noted, and "most of the patients are certainly cured of their disease."

The study is published in the April 11 issue of the New England Journal of Medicine.

Primary mediastinal B-cell lymphoma usually affects people in their teens to early 30s. Although many people with the disease who are treated with both chemotherapy and radiation do achieve a cure, roughly 20 percent do not, according to an NCI news release.

The research team noted that radiation to the chest area could also boost a patient's risk for other types of cancer down the road, including breast cancer, as well as cause damage to the heart. Complicating matters, as young people age, their risk for heart disease and new forms of cancer also rises.

The NIH trial involved 51 patients with untreated primary mediastinal B-cell lymphoma who were followed over the course of 14 years. The largest tumor diameter of any patient in the study was 11 centimeters.

Each patient received a regimen of drugs known as dose-adjusted EPOCH-R. The regimen included the following drugs: etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone and rituximab. The dosages of these drugs were adjusted to make them as effective as possible.


View the original article here

Wednesday, July 17, 2013

Cancer Patients May Be Unintended Victims of Budget Cuts

Title: Cancer Patients May Be Unintended Victims of Budget Cuts
Category: Health News
Created: 4/4/2013 2:35:00 PM
Last Editorial Review: 4/5/2013 12:00:00 AM

View the original article here

Monday, July 15, 2013

Cancer Patients May Be Unintended Victims of Budget Cuts

Clinics nationwide say they can't afford to give as much chemotherapy as before, report saysClinics nationwide say they can't afford to give

By Margaret Farley Steele

HealthDay Reporter

THURSDAY, April 4 (HealthDay News) -- Thousands of Medicare cancer patients are being denied treatment at clinics nationwide because of federal budget cuts related to the so-called sequester, according to a published report.

The mandated cuts took effect April 1, and cancer clinic administrators say they can no longer afford to provide expensive chemotherapy drugs to many Medicare patients, the Washington Post reported Wednesday. Medicare is the federal health insurance program for people 65 and older and certain others with disabilities.

After an emergency meeting Tuesday, one clinic administrator -- Jeff Vacirca, chief executive of North Shore Hematology Oncology Associates in New York -- told the Post that one-third of the group's 16,000 Medicare patients would be turned away.

"It's a choice between seeing these patients and staying in business," Vacirca told the newspaper. "The drugs we're going to lose money on we're not going to administer right now."

Hospitals, which also provide chemotherapy treatment, may offer an alternative, but it's not clear if they can accommodate the additional patients. Hospitals are also likely to charge more for treatment, and some of those extra costs will likely be borne by patients, said experts cited by the newspaper.

In terms of patients, the numbers are significant. Two-thirds of Medicare patients receive treatment in a community oncology clinic, rather than a hospital, according to a study by the Milliman actuarial firm, the Post reported.

This payment crunch is an unintended consequence of the sequester, some health care experts say. Congress limited Medicare to a 2 percent reduction -- less than that faced by other government programs -- but coverage of cancer drugs falls into a tricky area because they must be administered by a doctor. That puts them into the Medicare Part B category, which falls under the sequester cut, the Post reported.

"I don't think there was an intention to disrupt care or move it into a more expensive setting," said Cathy Schoen, senior vice president of the Commonwealth Fund, which works to promote a high-performing health-care system that achieves better access, improved quality and greater efficiency. "If that's the case, we're being penny-wise and a pound-foolish with these cuts," she told the Post.

Under current regulations, clinic oncologists receive federal reimbursement for the average price of cancer drugs, plus 6 percent for handling and administering them. Because doctors can't raise the drug price, the 2 percent cut has to come out of the 6 percent handling fee, they explained.

Some clinic administrators have urged lawmakers to shield cancer drugs from the sequester cuts, or put a 2 percent cap on reductions from their administrative reimbursement, the newspaper reported.

"We're hoping that something will change, as legislators see the impact of this," said Dr. Ralph Boccia, director of the Center for Cancer and Blood Disorders in Bethesda, Md.


View the original article here

Saturday, July 6, 2013

New Kind of Therapy Shows Early Promise in MS Patients

Approach may shield patients' immune systems to allow safer treatment, study suggestsApproach may shield patients' immune systems to

By Brenda Goodman

HealthDay Reporter

WEDNESDAY, June 5 (HealthDay News) -- A new therapy for multiple sclerosis that teaches the body to recognize and then ignore its own nerve tissue appears to be safe and well-tolerated in humans, a small new study shows.

If larger studies prove the technique can slow or stop the disease, the therapy would be a completely new way to treat autoimmune diseases such as multiple sclerosis (MS) and type 1 diabetes.

Most treatments for MS and other autoimmune diseases work by broadly suppressing immune function, leaving patients vulnerable to infections and cancers.

The new treatment targets only the proteins that come under attack when the immune system fails to recognize them as a normal part of the body. By creating tolerance to only a select few proteins, researchers hope they will be able to cure the disease but leave the rest of the body's defenses on guard.

"This is important work," said Dr. Lawrence Steinman, a professor of neurology at Stanford University who was not involved with the study.

"Very few investigators are trying therapies in humans aimed at simply turning off unwanted immune responses and leaving the rest of the immune system intact to fight infections -- to do surveillance against cancer," Steinman said. "The early results show encouragement."

For the study, published in the June 5 issue of the journal Science Translational Medicine, researchers in the United States and Germany recruited nine patients with MS. Seven had the relapsing-remitting form of the disease, while two others had secondary progressive MS (a more advanced phase). All were between the ages of 18 and 55, and were in good health except for their MS.

Blood tests conducted before the treatments showed that each patient had an immune reaction against at least one of seven myelin proteins.

Myelin is a white tissue made of fats and proteins that wraps nerve fibers, allowing them to conduct electrical signals through the body. In MS, the body attacks and gradually destroys these myelin sheaths. The damage disrupts nerve signals and leads to myriad symptoms, including numbness, tingling, weakness, loss of balance and disrupted muscle coordination.

Six patients in the study had low disease activity, while three others had a history of more active disease. Most were not experiencing symptoms at the time of their treatment.

On the day of the treatments, patients spent about two hours hooked up to a machine that filtered their blood, harvesting white cells while returning red cells and plasma to the body.

After the white cells were collected, they were washed and then combined with seven proteins that make up myelin tissue. A chemical was used to link the proteins to the white blood cells, which were dying.


View the original article here

Wednesday, July 3, 2013

Drug-Resistant 'Superbug' May Spread Among Patients, Study Finds

People with cystic fibrosis are of special concernPeople with cystic fibrosis are of special

By Robert Preidt

HealthDay Reporter

FRIDAY, March 29 (HealthDay News) -- Drug-resistant bacteria that cause lung infections in people with cystic fibrosis can be passed indirectly from person to person, a new study finds.

Between 3 percent and 10 percent of cystic fibrosis patients in the United States and Europe are infected with multi-drug resistant Mycobacterium abscessus, and the numbers are rising. The difficult-to-treat infection causes progressive lung damage.

In this study, researchers conducted DNA tracking of a multi-drug resistant M. abscessus outbreak that occurred among 31 cystic fibrosis patients at a British treatment center between 2007 and 2011.

Despite tight infection-control measures, patient-to-patient transmission was common, according to the study, published online March 29 in the journal The Lancet.

The researchers were unable to pinpoint the exact method of cross-infection between the patients. They said it likely occurred through contamination of things such as hair, clothing and bedding, or when bacteria were released into the air during procedures such as lung function tests.

The findings will have a major effect on how cystic fibrosis patients are cared for in hospitals and raise questions about the effectiveness of current infection-control measures and the risk of multi-drug resistant M. abscessus cross infection in other groups of patients, said Dr. Andres Floto, of the University of Cambridge, and colleagues.


View the original article here

Monday, July 1, 2013

Drug-Resistant 'Superbug' May Spread Among Patients, Study Finds

Title: Drug-Resistant 'Superbug' May Spread Among Patients, Study Finds
Category: Health News
Created: 3/29/2013 10:35:00 AM
Last Editorial Review: 3/29/2013 12:00:00 AM

View the original article here

Friday, June 28, 2013

Early Thinking Problems May Signal Future Dementia in Parkinson's Patients

Title: Early Thinking Problems May Signal Future Dementia in Parkinson's Patients
Category: Health News
Created: 3/25/2013 4:36:00 PM
Last Editorial Review: 3/26/2013 12:00:00 AM

View the original article here

Monday, June 24, 2013

Certain Lifestyle Factors Linked to Arthritis in Study Patients

Title: Certain Lifestyle Factors Linked to Arthritis in Study Patients
Category: Health News
Created: 3/25/2013 2:35:00 PM
Last Editorial Review: 3/26/2013 12:00:00 AM

View the original article here

Wednesday, June 12, 2013

Involving Patients in Decisions Raises Health Care Costs, Study Finds

Those who delegate medical decisions to their doctor have shorter hospital stays, researchers sayWomen with BRCA variant found to have better

By Mary Elizabeth Dallas

HealthDay Reporter

TUESDAY, May 28 (HealthDay News) -- Although doctors and patients have long been urged to share decision-making, new research finds that patients who are involved in their care spend more time in the hospital and increase the cost of their hospital stay.

Researchers at the University of Chicago Medical Center found that patients who share in decision-making raise the cost of their admission by an average of $865.

"The result that everyone would have liked -- that patients who are more engaged in their care do better and cost less -- is not what we found in this setting," the study's author, Dr. David Meltzer, associate professor of medicine, economics and public policy at the University of Chicago, said in a university news release. "Patients who want to be more involved do not have lower costs. Patients, as consumers, may value elements of care that the health care system might not."

The researchers said there are roughly 35 million hospitalizations each year in the United States. They calculated that if 30 percent of those patients shared in decision-making on their care instead of allowing their doctor to call the shots, it would result in $8.7 billion in additional costs every year.

Meltzer said he was not surprised by the findings. "I wasn't shocked. It could have gone either way. Our results suggest that encouraging patients to be more involved will not, alone, reduce costs," he said. "We need to think harder and learn more about what it means to empower patients in multiple health care settings and how incentives facing both patients and caregivers in those settings can influence decisions."

For the study, which was published in the May 27 issue of the journal JAMA Internal Medicine, the researchers asked all patients admitted to the University of Chicago's general internal medicine service between July 2003 and August 2011 to complete an extensive survey. Nearly 22,000 people participated.

The surveys revealed that 37.6 percent of the patients felt strongly about wanting to leave the decision-making on their medical care to their doctor. Another 33.5 percent agreed somewhat and 28.9 percent disagreed with that approach.

The patients who preferred to work with their doctor rather than delegate decisions spent roughly 5 percent more time in the hospital and incurred about 6 percent higher costs, the study found.

The researchers also considered patients' insurance. They found that provider incentives to use fewer services were not the only predictors of care costs. Although uninsured patients had shorter stays and lower hospitalization costs, those with public insurance that pays less than the cost of care had longer than average admissions and higher costs.

The study's authors also said 75 percent of the patients involved in the study were black and more than half of the participants had a high school education or less. They said 80 percent were covered by Medicare or Medicaid or were uninsured.

"This isn't about demographics," Meltzer said. The study showed that patients with the most education had lower costs than those with the least education.

"We want patients to be more involved, to have the richest form of interaction," Meltzer said. "That can align preferences, prevent mistakes and avoid treatments patients don't want. But we need to find ways to create functional doctor-patient partnerships that lead to good health as well as sound decisions about resource utilization."

The researchers also said, however, that their findings may not apply in every hospital setting.


View the original article here

Alzheimer's Patients Mimic Emotions of Those Around Them: Study

Findings may have implications for caregiversFindings may have implications for caregivers.

By Steven Reinberg

HealthDay Reporter

TUESDAY, May 28 (HealthDay News) -- People with Alzheimer's disease or early thinking and memory problems tend to mirror the emotions of those around them, researchers find.

This transfer of emotions, known as emotional contagion, appears heightened in people with Alzheimer's and related mental decline, according to the University of California, San Francisco (UCSF) team. And it can be important in the management of these patients, they added.

"Calm begets calm," said Dr. Sam Gandy, associate director of the Mount Sinai Alzheimer's Disease Research Center in New York City, who was not involved in the study.

Emotional contagion is a rudimentary form of empathy, enabling people to share and experience other people's emotions, said lead researcher Virginia Sturm, an assistant professor in the UCSF department of neurology.

"It's a way by which emotions travel across people quickly and even without awareness," explained Sturm. This process can shape behaviors and cause changes in the brain, she added.

In the early stages of Alzheimer's disease and in people with mild thinking and memory problems, emotional contagion increases, the researchers found. It is even more apparent in people with dementia, they noted.

"In Alzheimer's disease and other dementia we think some people may have an increased sensitivity to other people's emotions," Sturm said.

"As their memory and thinking abilities decline, it seems this is accompanied by the enhancement of other emotional processes," she said.

This means that if caregivers are anxious or angry, their patients will pick up and copy these emotions.

On the other hand, if the caregiver is calm and happy, patients will emulate these positive emotions, Sturm said.

"This is a way Alzheimer's patients connect with others, even though they don't have an understanding of the social situation," she said. "In order to manage patients, it might be that the caregivers being calm and happy would go a long way in keeping their patient calm and happy."

Alzheimer's disease is an age-related brain disorder that begins slowly and gradually robs people of their ability to lead their everyday lives. In the United States, one-third of the nation's seniors die with Alzheimer's or another type of dementia, according to the Alzheimer's Association.

The study, published online May 27 in the Proceedings of the National Academy of Sciences, involved 237 adults. Sixty-two patients had mild memory and thinking problems and 64 had Alzheimer's disease. The others were mentally healthy.

Participants took tests to identify depression and other mental health problems and also underwent MRI scans to identify changes in the brain related to emotional contagion.

The researchers found higher emotional contagion in those with mild mental impairment and Alzheimer's disease, compared with those who did not have these conditions.

This growth of emotional contagion paralleled the increase in damage to the right temporal lobe of the brain, reflecting biological changes in the neural system, the study found.

"The right temporal lobe is important for different aspects of emotion and social behavior," Sturm said.

Depression was also greater among those with mild mental impairment and Alzheimer's disease, the study found.

From a neurologist's perspective, "it is extraordinary that something so complex as emotional perception can be controlled by such a localized part of the brain," Gandy said.

"Also, classically it has been the frontal lobe damage that leads to emotional disturbance," Gandy added. "Now we know the temporal lobes can play similar roles."


View the original article here

Monday, June 10, 2013

Anxiety, Depression May Triple Risk of Death for Heart Patients: Study

Researcher recommends stress-reducing measuresResearcher recommends stress-reducing measures.

By Steven Reinberg

HealthDay Reporter

TUESDAY, March 19 (HealthDay News) -- Anxiety and depression coupled with heart disease triples the risk of death compared to cardiac trouble alone, researchers have found.

Among heart patients, anxiety can double the risk of dying from any cause, the study authors noted, and depression further raises those odds.

"Patients with heart disease who experience high anxiety during the stressors of everyday life may benefit from treatments designed to reduce anxiety, such as medications targeting anxiety or stress management," said lead researcher Lana Watkins, an associate professor of psychiatry and behavioral sciences at Duke University Medical Center in Durham, N.C.

"Benefits from stress-reducing interventions would potentially be greatest in patients where anxiety is found in combination with depression," she added.

Previous studies have shown that depression is about three times more common in heart attack patients than in others. But few studies have looked at anxiety's effect or the combination of the two on heart disease patients.

One expert, Dr. Gregg Fonarow, a spokesman for the American Heart Association and a professor of cardiology at the University of California, Los Angeles, agreed anxiety and depression are most lethal when they co-exist.

"Depression and anxiety have both been individually associated with a higher risk of developing cardiovascular disease, and in patients with cardiovascular disease [they are] associated with higher risk of recurrent cardiovascular events and death," Fonarow said.

This new study finds that anxiety, particularly when accompanying depression, independently increased risk of dying, he added.

The report was published March 19 in the Journal of the American Heart Association.

Anxiety is a common mental health problem, with about one-third of U.S. adults experiencing an anxiety disorder in their lifetime, the researchers noted. And heart disease is the leading cause of death in the United States.

For the study, more than 900 heart disease patients, average age 62, answered a questionnaire measuring their level of anxiety and depression right before or just after coronary angiography, which can be a stressful cardiac procedure. The test uses special X-rays and dyes to view the coronary arteries.

The investigators found that 90 patients had anxiety, 65 had depression and 99 suffered from both.

Of the 133 patients who died over the three years of follow-up, 55 suffered from anxiety, depression or both, the researchers reported. Most of these deaths (93) were related to heart disease, they noted.

Patients who are highly anxious during a stressful life experience, such as a cardiac hospitalization, are at an increased risk of dying, and this risk is independent of the severity of their heart disease and also of depression, Watkins said.

According to the researchers, anxiety can increase inflammation and blood pressure. Fatigue or feelings of worthlessness associated with depression may cause people to ignore their treatment for heart disease.


View the original article here